OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
43 hedge funds and large institutions have $465M invested in Oyster Point Pharma, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+2
Holders Change %
+4.88%
% of All Funds
0.95%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
9
Increased
12
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$33.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.64M |
| 3 |
First Manhattan
New York
|
+$3.32M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.82M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$736K |
Top Sellers
| 1 |
VM
VV Manager
Boston,
Massachusetts
|
-$23.5M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$5.95M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.64M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$5.15M |
| 5 |
BlackRock
New York
|
-$1.47M |
